Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

112 results about "Barrier permeability" patented technology

The permeability barrier of the skin which prevents transcutaneous water loss and penetration of harmful drugs from the environment is localized in the horny layer of the epidermis.

Novel nano-drug Res (at) LDH as well as preparation method and application thereof

The invention discloses a novel nano-drug Res (at) LDH and a preparation method and application thereof.Germanium-doped LDH powder and resveratrol are combined to obtain a nanoscale particle mixed material Res (at) LDH, electron paramagnetic resonance (EPR) tests show that both the germanium-doped LDH and the traditional drug resveratrol show excellent reactive oxygen species (ROS) removal characteristics, and the Res (at) LDH can be used for preparing a novel nano-drug Res (at) LDH. The nano-drug Res (at) LDH formed by combining the two has remarkable synergistic ROS removal efficiency which can reach 90%. Meanwhile, in-vivo biological distribution experiments show that the novel nano-drug Res (at) LDH has excellent blood-brain barrier permeability, enhances accumulation in brain tissues, improves neurological dysfunction, reduces infarct volume, shows strong antioxidant activity, and inhibits release of pro-inflammatory cytokines.
Owner:BEIJING TONGREN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV

Focused ultrasound open blood brain barrier effect prediction method and system, medium and terminal

The invention provides a focused ultrasound blood brain barrier opening effect prediction method and system, a medium and a terminal, and the method comprises the steps: carrying out the preprocessing of all collected acoustic signal data, and constructing a training data set based on the blood brain barrier opening effect data; training a deep learning model by using the training data set to construct a blood brain barrier prediction model; and on the basis of the blood brain barrier prediction model, predicting the permeability of the blood brain barrier according to the obtained real-time acoustic signal data of the ultrasonic contrast agent in the process of regulating and controlling the blood brain barrier so as to output a blood brain barrier opening effect prediction result. The acoustic signals are analyzed based on the artificial intelligence algorithm, a magnetic resonance contrast agent does not need to be injected, the long-time scanning process is avoided, safe and rapid prediction of the blood brain barrier permeability is achieved, and the test cost is reduced. Compared with a dye tracing method, the blood brain barrier permeability prediction method based on artificial intelligence does not need to perform any operation on a target test, is convenient and rapid, and has a living body detection capability.
Owner:SHANGHAI TECH UNIV

Xanthine oxidase inhibitory peptide derived from green and sweet tuna and application of xanthine oxidase inhibitory peptide

The invention relates to a xanthine oxidase inhibitory peptide derived from green and sweet tuna and application of the xanthine oxidase inhibitory peptide, and belongs to the technical field of polypeptides, and the amino acid sequence of the xanthine oxidase inhibitory peptide is Trp-Thr-Ala (WTA), Trp-Val-Pro (WVP), Trp-Leu-Pro (WLP) or Trp-Gly-Phe (WGF). The invention also provides an application of the inhibitory peptide as or in preparation of a xanthine oxidase inhibitor and an application of the inhibitory peptide as or in preparation of a medicine with an effect of inhibiting uric acid level. The invention also provides a xanthine oxidase inhibitor containing at least one inhibitory peptide or a composition or functional food for inhibiting uric acid. The selected inhibitory peptide is a novel food-borne XO inhibitory peptide, is good in water solubility, non-toxic and good in small intestine absorption and blood brain barrier permeability, has the potential of serving as a xanthine oxidase inhibitor and reducing the uric acid level, and can be used for preparing a medicine for preventing and treating hyperuricemia or serving as a functional food additive.
Owner:SANYA INST OF OCEANOGRAPHY OCEAN UNIV OF CHINA

Lactoferrin nanometer material for sonodynamic regulation and control of permeability of blood-brain barrier and preparation method and application of lactoferrin nanometer material

The invention belongs to the technical field of medical nano-materials, and particularly relates to a lactoferrin nano-material for sonodynamic regulation and control of blood-brain barrier permeability as well as a preparation method and application of the lactoferrin nano-material. The nanomaterial is nanoparticles LCe6 formed by self-assembly of lactoferrin and chlorin e6, can target brain microvascular endothelial cells, and can temporarily, reversibly and targeting open BBB by using the sonodynamic effect of the LCe6 in combination with transcranial ultrasonic stimulation, so that the accumulation of the nanoparticles LCe6 at a focus part is improved; in addition, the nanoparticle LCe6 also has a targeting property on brain tumor cells, the tumor cells can be accurately killed by utilizing the sonodynamic effect of the nanoparticle under secondary transcranial ultrasound, and the effect of sonodynamic treatment on brain glioma is exerted to the maximum extent; the nanoparticles LCe6 have excellent biocompatibility and low toxicity; according to the invention, the intracerebral delivery efficiency of the drug can be obviously improved, and a novel method for targeting open brain disease BBB is provided.
Owner:SOUTHERN MEDICAL UNIVERSITY

Macrophage-polymer lipid nanoparticle composite drug delivery system, preparation method thereof and application of macrophage-polymer lipid nanoparticle composite drug delivery system in cryptococcus infection resistance

The invention discloses a macrophage-polymer lipid nanoparticle composite drug delivery system, a preparation method thereof and application of the macrophage-polymer lipid nanoparticle composite drug delivery system in cryptococcus infection resistance. According to the drug delivery system, alpha-linolenic acid (ALA), high molecular weight chitosan oligosaccharide (HCOS) and amphotericin B (AmB) are used as raw materials to construct nanoparticles AmB-PLHNs, the nanoparticles are loaded in macrophages through the phagocytosis of the macrophages, and the AmB-PLHNs (at) M1 is constructed. AmB is a common medicine for clinically treating Cn infection, but has the problems of toxic and side effects on kidney and incapability of being transferred into the center. The AmB-PLHNs (at) M1 carries AmB-PLHNs to be transferred into the brain according to the blood-brain barrier penetrating characteristic of M1 type macrophages, and the brain entering efficiency of the medicine is improved. By combining the phagocytosis of macrophages on cryptococcus, the inflammation immune regulation function of the macrophages and the bacteriostatic action of the drug-loaded nanoparticles, the drug-loaded nano-particles are used for treating Cn central infection, and the toxic and side effects of AmB are reduced.
Owner:THE NAVAL MEDICAL UNIV OF PLA

Stilbene glucoside and tanshinone IIA combined liposome and preparation method thereof

The invention relates to a brain-targeted stilbene glucoside and tanshinone IIA loaded combined liposome for treating Alzheimer's disease and improving learning and memory ability disorders and a preparation method thereof. The composition comprises a modification factor Angiopep-2, a liposome carrier, stilbene glucoside and tanshinone IIA. Angiopep-2 is used as a target head, and a film dispersion and ammonium sulfate gradient method is adopted to prepare the liposome. According to the present invention, the problems of poor solubility and low bioavailability of stilbene glucoside and tanshinone IIA are solved, and the Angiopep-2 and the blood brain barrier (BBB) surface LRP-1 are subjected to specific recognition and are combined to enter the brain, such that the blood brain barrier transmittance of the drug is increased, and the targeting ability of the drug is improved. The traditional Chinese medicine composition has a good application prospect in the aspects of treating the Alzheimer's disease and improving learning and memory dysfunction.
Owner:SHENZHEN NEPTUNUS PHARMA RES INST CO LTD

Composition based on synergistic effect of SOD-LF covalent conjugate and neuromodulation and application of composition in preparation of drugs for relieving anxiety and insomnia and improving sleep quality

The invention discloses a composition based on the synergistic effect of an SOD-LF covalent conjugate and neuromodulation and application of the composition in preparation of drugs for relieving anxiety and insomnia and improving sleep quality, and belongs to the technical field of biology. The preparation method comprises the following steps: preparing an SOD-LF covalent conjugate from lactoferrin and SOD; uniformly dispersing the SOD-LF covalent conjugate in a sodium alginate solution, spraying into a calcium chloride solution, standing, and filtering to obtain a sodium alginate coated SOD-LF covalent conjugate; and dispersing the sodium alginate coated SOD-LF covalent conjugate and fucoidin in a chitosan solution, adding sodium tripolyphosphate, stirring for reaction, and centrifugally collecting to obtain the composition based on the synergistic effect of the SOD-LF covalent conjugate and nerve regulation. According to the composition disclosed by the invention, the blood brain barrier transmittance is enhanced through the SOD-LF covalent conjugate, and the fucoidin is combined to regulate the intestinal flora-enteric brain axis to synergistically inhibit neuroinflammation and oxidative stress, so that anxiety and insomnia are improved.
Owner:SIPING HUAKE BIOLOGICAL TECH

A method for predicting compound blood-brain barrier permeability based on ternary mixed-level fusion convolutional neural network

The present invention proposes a compound blood-brain barrier permeability prediction method based on a ternary mixed-level fusion convolutional neural network, and the specific implementation steps are as follows: (1) for the acquired compound, extract the SMILES expression and molecular structure diagram of the compound; (2) perform data preprocessing operations: extract MGF, MFF and MDF, obtain P-MGF, P-MFF, P-MDF respectively through feature screening, and normalize P-MGF, P-MFF, and P-MDF in turn to obtain,,; (3) construct a ternary mixed-level fusion convolutional neural network, design a ternary module to process,, three feature sets, obtain the processing results through the splicing layer fusion, and use the fully connected layer and the output layer for processing in turn; (4) input,,, into the ternary mixed-level fusion convolutional neural network, adjust the parameters to obtain the best prediction network; (5) apply the best prediction network to the prediction of the compound sample to be tested.
Owner:BEIJING JINHUIGU TECH CO LTD

Car-t cell having good blood-brain barrier permeability, product, and use

Provided are a CAR-T cell having good blood-brain barrier permeability, a product, and a use. On the basis of the research on CAR-T cell therapy for central nervous system diseases, provided are a CAR-T cell having good blood-brain barrier permeability and a corresponding drug, for use in treating or relieving central nervous system diseases. Such a CAR-T cell uses a B cell maturation antigen as a target, and highly expresses a CXCR3 chemokine receptor and CCL1, CCL3 and CCL4 chemokines. Also provided is a product for testing and determining the blood-brain barrier permeability of the CAR-T cell, e.g., a probe, a reagent, and a kit, thereby accurately testing and determining the blood-brain barrier permeability of a certain CAR-T cell.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV

A brain-targeted nanocarrier and its preparation method and application

This invention belongs to the field of drug carrier technology and discloses a brain-targeted nanocarrier, its preparation method, and application. The primary raw materials for preparing the brain-targeted nanocarrier include PLGA-PEG-NHS, D-mannosamine, and a sulfide donor. This brain-targeted nanocarrier utilizes the dual targeting effects of mannose and sulfide to not only target the brain but also effectively improve blood-brain barrier permeability. With its high targeting and high permeability, it can be used as a carrier to effectively deliver therapeutic drugs to the brain to exert therapeutic effects, and has promising application prospects.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Method for improving blood brain barrier permeability

The invention discloses a black phosphorus-methylene blue nano composition for improving blood brain permeability and a synthesis method thereof. The synthesis method comprises the following steps: step 1, mixing black phosphorus nanosheets with polyethylene glycol for reaction; step 2, carrying out centrifugal cleaning on the reaction liquid in the step 1, and collecting a lower-layer reactant; step 3, adding aminated superparamagnetic nanoparticles and methylene blue into the lower reactant obtained in the step 2 for reaction; and 4, carrying out centrifugal cleaning on the reaction liquid obtained in the step 3, and collecting a lower-layer reactant. The invention also discloses the black phosphorus-methylene blue nano composition synthesized by the synthesis method, the drug loading rate of methylene blue in the composition exceeds 60%, and the composition has good biological safety, is non-toxic to cells and mice, is very simple and convenient in preparation process, and has a wide application prospect in the aspect of improving the blood-brain barrier permeability.
Owner:SHENZHEN UNIV

System for noninvasive regulation and control of blood brain barrier permeability in transcranial pulsed electric field

PendingCN121102730AArtificial respirationElectrical stimulationsBbb permeability
A system for noninvasive regulation and control of blood brain barrier permeability through a transcranial pulsed electric field comprises a high-voltage pulse generator and a plurality of treatment electrodes. The connection tightness of endothelial cells is adjusted through a high-voltage short-pulse electric field, local regulation and control of the brain area are achieved in combination with electrode design, pulse parameters are flexibly adjusted to balance the effect and damage, and a new non-invasive physical treatment means is provided for assisting drug cross-blood-brain-barrier delivery. Compared with focused ultrasound, the multi-mechanism synergistic effect (electroporation effect and bioelectrochemical effect) is utilized instead of depending on the mechanical effect of exogenous microbubbles, so that the safety risk is remarkably reduced. The method has the advantages of noninvasiveness, high efficiency and safety, and can achieve a multi-mechanism synergistic effect. The non-invasive electrode is used for delivering instantaneous high-voltage electric pulses, which is different from conventional low-voltage long-time electric stimulation.
Owner:金凤实验室

Blood-brain barrier permeability regulator

The purpose of the present invention is to provide a novel blood-brain barrier permeability regulator. The present invention pertains to a blood-brain barrier permeability regulator containing a compound represented by formula (I) (Symbols in the formula (I) are as defined in the present specification.) or an isomer thereof, or a salt thereof. The present invention also pertains to a medicine for preventing and / or treating various brain diseases, severe infections, or sepsis by using the compound or an isomer thereof, or a salt thereof alone or in combination with a drug for preventing and / or treating a brain disease.
Owner:OSAKA UNIVERSITY +1

Flavone derivative delivery system of targeted EGFR (epidermal growth factor receptor) protein as well as preparation method and application of flavone derivative delivery system

The invention discloses a flavone derivative delivery system of targeted EGFR (Epidermal Growth Factor Receptor) protein as well as a preparation method and application of the flavone derivative delivery system, and belongs to the technical field of medicinal chemistry. The flavonoid derivative HT11 with anti-A beta and antioxidant activity is synthesized firstly, the depolymerization effect of the flavonoid derivative HT11 on A beta 1-42 reaches up to 92.40%, and the flavonoid derivative HT11 has good blood-brain barrier permeability. Then, the HT11 is loaded by taking the graphene oxide quantum dot as a carrier to obtain the HT11 coated GOQDs, so that the defect of low solubility of the HT11 is effectively overcome, and the targeting property and the curative effect of the HT11 coated GOQDs can be enhanced. Experimental results show that the HT11-coated GOQDs effectively solve the problem of reduction of AD animal space learning and memory ability, and possibility is provided for application of the HT11-coated GOQDs in the field of biological medicine.
Owner:FUJIAN MEDICAL UNIV

ICA1L derived peptide and application thereof in relieving Alzheimer disease A beta pathology

The invention discloses ICA1L derived peptide and application thereof in relieving Alzheimer disease A beta pathology. The amino acid sequence of the ICA1L derived peptide is shown as SEQ ID NO.01. The invention further discloses a preparation method of the ICA1L derived peptide. The compound can be combined with low-density lipoprotein receptor associated protein 1 (LRP1), inhibit K48 connection type ubiquitination of the LRP1 and prevent degradation through a proteasome pathway, so that the protein level of the LRP1 is stabilized, and the expression of beta-site APP lyase 1 is reduced to reduce the generation and deposition of beta-amyloid protein. In vitro, the peptide shows good biocompatibility and cell uptake ability; in vivo, the peptide has blood-brain barrier permeability, can be positioned in neurons, can significantly reduce hippocampus and cortex A beta plaque deposition in a 5xFAD mouse model through caudal vein injection, reduces BACE1 and beta-CTF levels, and improves the cognitive function. The invention further discloses an ICA1L-LRP1 regulatory axis, and a new strategy is provided for treatment of the Alzheimer's disease.
Owner:XIAMEN UNIV

Hydrophobic tag compound for targeted degradation of Tau protein as well as preparation and application of hydrophobic tag compound

The invention discloses a hydrophobic tag compound for targeted degradation of Tau protein as well as preparation and application of the hydrophobic tag compound, the compound is a small-molecule degradation agent with low molecular weight, good degradation effect and good blood brain barrier permeability, and the preparation method of the compound is characterized in that a hydrophobic tag technology is adopted to prepare the hydrophobic tag compound for targeted degradation of Tau protein. A small molecule Tau protein ligand is connected with a hydrophobic tag structure fragment with hydrophobicity through a proper linking chain (Linker), so that the blood-brain barrier permeability of the compound is improved on the basis of generating Tau protein degradation activity, and the compound has important application potential in treatment of neurodegenerative diseases.
Owner:CHINA PHARM UNIV

A method and system for screening compounds that modulate blood-brain barrier permeability

The application discloses a kind of compound screening method and system for regulating blood-brain barrier permeability, it is related to medical screening technical field, the specific steps of the method are as follows: S100, collect blood-brain barrier related cell multi-omics data to form original set;S200, data is preprocessed and standardized;S300, molecular network is constructed by cross-omics analysis, and key target is screened;S400, target information is integrated to establish structured target pool;S500, effective compound for regulating blood-brain barrier permeability is screened out by molecular docking and primary cell verification, the application constructs gene-protein-metabolite network by multi-omics integration and cross-omics analysis, accurately identifies blood-brain barrier key target, provides high credibility target pool;Combined with molecular docking and primary cell mixed culture verification, realize efficient screening and functional safety evaluation of candidate compound, significantly reduce research and development cost, provide efficient technical path for drug research and development.
Owner:THE PEOPLES HOSPITAL SHAANXI PROV

Traditional Chinese medicine composition for blood-brain barrier permeability after cerebral apoplexy and preparation method of traditional Chinese medicine composition

The invention belongs to the technical field of cerebral apoplexy treatment, and discloses a traditional Chinese medicine composition for blood brain barrier permeability after cerebral apoplexy and a preparation method thereof, and the traditional Chinese medicine composition comprises the following raw materials: angelica sinensis, radix paeoniae alba, astragalus membranaceus, elecampane, pinellia ternate, mangnolia officinalis, caulis bambusae in taeniam, immature bitter orange, pericarpium citri reticulatae, bighead atractylodes rhizome, ligusticum wallichii, lumbricus, codonopsis pilosula and liquidambar formosana hance. The traditional Chinese medicine is used for treating cerebral arterial thrombosis with symptoms of turbid phlegm, blood stasis, brain collaterals and deficiency of healthy qi. The traditional Chinese medicine composition has the effects of reducing phlegm, activating blood, tonifying qi and strengthening the body resistance, and has a treatment effect on the pathological characteristics of cerebral arterial thrombosis such as blockage of brain collaterals due to turbid phlegm and blood stasis and deficiency of healthy qi.
Owner:REHABILITATION HOSPITAL AFFILIATED TO CHONGQING MEDICAL UNIV

Compound capable of increasing blood-brain barrier permeability, preparation method thereof and application thereof

The present invention relates to the technical field of compound synthesis, and in particular, to a compound capable of enhancing the permeability of the blood-brain barrier, a preparation method thereof, and an application thereof. The compound capable of enhancing the permeability of the blood-brain barrier has the following structural formula: wherein X represents a halogen, R1 represents a C1-C5 alkyl, and R represents a substituted or unsubstituted alkyl and a substituted or unsubstituted phenyl. The compound has a high blood-brain barrier permeability, and can then enter the brain more quickly, which is beneficial for the compound to exert its pharmacological effect. At the same time, the compound can simultaneously inhibit ALK and EGFR, and can serve as a dual inhibitor of ALK and EGFR, and has a good therapeutic effect on cancers such as non-small cell lung cancer, anaplastic lymphoma, lung adenocarcinoma, and glioma.
Owner:SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL

A midazolam nanocrystal suspension for needle-free injection, a preparation method thereof and application thereof

This invention relates to a midazolam nanocrystal suspension, which, by weight-volume percentage, comprises 5%–45% midazolam, 1%–10% Tween, and 0.1%–10% sodium deoxycholate (SDC). The midazolam nanocrystal suspension of this invention exhibits superior blood-brain barrier permeability and bioavailability, making it suitable for needle-free injection administration.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Brain-targeted nano drug delivery system, preparation method and application

PendingCN119280426AImprove bioavailabilitySmall toxicityPowder deliveryAntipyreticBlood brain barrier penetrationHistidine
The invention belongs to the technical field of biological medicine, and discloses a brain-targeted nano drug delivery system, a preparation method and application. According to the invention, dipentaerythritol-polycaprolactone-histidine (DPE-PCL-HIS) is used as a basic drug carrier, and drug curcumin (Cur) molecules are entrapped in a physical embedding manner; and modifying bovine serum albumin (BSA) grafted with a bifunctional intermediate connection compound 4-(N-maleimide methyl) cyclohexane-1-carboxylic acid 3-sulfo-N-hydroxysuccinimide ester sodium salt (Sulfo-SMCC) on a precoating layer, and finally connecting an apolipoprotein E mimic peptide as a brain-targeting ligand, so as to construct the brain-targeting bionic protein crown nano drug delivery system, wherein the bovine serum albumin (BSA) is grafted with the bifunctional intermediate connection compound 4-(N-maleimide methyl) cyclohexane-1-carboxylic acid 3-sulfo-N-hydroxysuccinimide ester sodium salt (Sulfo-SMCC). According to the prepared brain-targeted nano drug delivery system, apolipoprotein E mimic peptide [RLLRKRLK (PEG2000) RLGWC] is used as a ligand and enters the brain under the transendocytosis action of the apolipoprotein E mimic peptide [RLLRKRLK (PEG2000) RLGWC] and a blood-brain barrier (BBB) surface receptor, the blood-brain barrier permeability of a drug is increased, the brain targeting property and bioavailability of drug-loaded nanoparticles are improved, and the brain-targeted nano drug delivery system has wide application prospects in the aspect of treating brain diseases.
Owner:ZHEJIANG UNIV OF TECH

Fusion protein comprising GLP-1, immunoglobulin fc, and IGF-1 and use thereof

The present invention relates to a fusion protein comprising GLP-1, immunoglobulin Fc region, and IGF-1, and use thereof. The fusion protein of the present invention has excellent efficiency in blood-brain barrier permeability, and thus can be widely used for the effective treatment of neurological diseases.
Owner:IMMUNOFORGE CO LTD

Citicoline dextrophan derivatives, process for their preparation and use

The present application relates to a kind of cytidine choline dextrohydrotalcid derivatives and its preparation method and application, belong to biological medicine technical field.The present application is aimed at solving the technical problems of low blood-brain barrier penetration rate and limited treatment effect of existing edaravone dextrohydrotalcid compound preparation.The present application prepares a dextrohydrotalcid derivative (C-B) with boronic acid structure, then it is compounded with cytidine choline in specific pH buffer system, and forms cytidine choline dextrohydrotalcid derivative (C-D-B).The present application can effectively improve the efficiency of drug crossing blood-brain barrier by using the dynamic covalent characteristics of boronic ester bond and free radical responsiveness.The experimental results show that, compared with existing combination drug, the derivative of the present application can significantly reduce the infarction area of cerebral ischemia model animal, reduce cell damage and active oxygen level, and promote vascular regeneration, and show better treatment effect on ischemic brain injury.
Owner:CHONGQING UNIV

Polypeptide modified black phosphorus nanosheet composite material for brain targeting and preparation method thereof

The invention discloses a polypeptide-modified black phosphorus nanosheet composite material for brain targeting and a preparation method thereof, the invention provides the polypeptide-modified black phosphorus nanosheet composite material for brain targeting and the preparation method thereof, and the black phosphorus nanosheet composite material has good drug loading capacity and excellent photo-thermal capacity, and can be applied to brain targeting. The problem of solubility of the resveratrol is solved, and the bioavailability of the resveratrol is improved. The black phosphorus nanosheet composite material disclosed by the invention is modified by ANG polypeptide, penetrates through a blood brain barrier through LRP-1 receptor mediated endocytosis and enters the brain, and has an obvious brain targeting characteristic. Meanwhile, under near-infrared illumination, the blood-brain barrier permeability of the black phosphorus nanosheet composite material can be further improved. The black phosphorus nanosheet composite material disclosed by the invention has a remarkable treatment effect on ischemic brain injury under the conditions of polypeptide modification and near-infrared illumination.
Owner:SHIHEZI UNIVERSITY

Application of α-asarone in preparing medicine for preventing or treating hemorrhagic stroke

The present invention provides the use of α-asarone in the preparation of a drug for preventing or treating hemorrhagic stroke. The structure of α-asarone is shown in Formula I. It can significantly improve short-term neurological deficits and long-term learning and memory function in model rats, reduce cerebral edema, improve blood-brain barrier permeability, and prevent or alleviate brain tissue atrophy during the recovery period. It has a definite therapeutic effect on animal models of hemorrhagic stroke without significant toxic side effects, and is expected to become a promising drug for the prevention and treatment of hemorrhagic stroke. #imgabs0#
Owner:CHENGDU XINRUI TAIKANG TECH CO LTD

Heterodimer compounds targeting nmda receptor-ca2+ channel, and preparation method and application thereof

This invention discloses a method using NMDA receptor-Ca 2+ Channel-targeted heterodimer compounds, their preparation methods, and applications, including NMDA receptor-Ca 2+ The structural formulas of channel heterodimers are represented by the following formulas (I-a), (I-b) and (II), (III): The heterodimer compounds of the present invention have multiple effects, including inhibiting NMDA receptors, reducing glutamate-induced NMDA receptor overexcitation and inhibiting calcium ion influx, inhibiting platelet aggregation, dilating blood vessels, and improving cognitive function. They also have high blood-brain barrier permeability and can be used for the prevention and treatment of vascular dementia.
Owner:HEFEI UNIV OF TECH

Preparation of 3-amino indazole covalent compound and application of 3-amino indazole covalent compound in treatment of Parkinson's disease

The invention relates to preparation and application of a 3-amino indazole covalent compound, and belongs to the technical field of medicines. The technical problem to be solved by the invention is to provide the 3-amino indazole covalent inhibitor compound targeting JNK3. The compound comprises a compound as shown in the specification or a pharmaceutically acceptable salt thereof. The compound or the pharmaceutically acceptable salt thereof disclosed by the invention is a JNK3 selective covalent inhibitor, has the activity of inhibiting JNK3 protein and the activity of resisting Parkinson's disease, and shows an excellent neuroprotective effect. The compound disclosed by the invention is preferably an anti-Parkinson's disease compound, and is characterized by being a JNK3 covalent inhibitor with reasonable blood-brain barrier permeability, low toxicity and high selectivity. # imgabs0 wherein R1 is # imgabs1 # imgabs2 # imgabs2 #, R2 is # imgabs3 # imgabs4 #, and R3 is # imgabs5 # imgabs6 #
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Xav939-based n-carbonyl-substituted sulfur-containing fused pyrimidinone derivatives, and synthetic methods and applications thereof

The application belongs to the technical field of biological medicine, and particularly relates to an N-carbonyl-substituted sulfur-containing fused pyrimidinone derivative based on XAV939 as well as a synthesis method and application thereof. The application provides a compound structure with a sulfur-containing fused pyrimidinone skeleton. The application introduces a carbonyl substituent at a specific nitrogen site of a parent nucleus, effectively improves pharmacokinetic properties of the compound XAV939, improves blood-brain barrier permeability, and realizes systemic administration. In addition, the application has a high bioavailability, and can be used for treating autism spectrum disorders. Shank3b In mutant autism model mice, the N-carbonyl-substituted sulfur-containing fused pyrimidinone derivative based on XAV939 first proposed by the application can significantly inhibit Wnt-glycolysis signals, improve social barriers, and has no obvious cytotoxicity, thereby providing a new drug selection for treating autism spectrum disorders.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Liposome and application thereof, liposome preparation and preparation method and application thereof

The invention belongs to the technical field of liposome pharmaceutical preparations, and particularly relates to a liposome and application thereof, a liposome preparation and a preparation method and application thereof. The invention provides a liposome. A glutathione group and an indole residue are modified on a liposome membrane. The lipidosome provided by the invention has excellent transmembrane transport capacity, can efficiently penetrate through a blood-brain barrier and can be taken by glioma cells, and also shows excellent endosome escape characteristic, so that the technical problem of low blood-brain barrier transmittance in the glioma treatment process of temozolomide is effectively solved. Meanwhile, the invention provides a liposome preparation, the delivery efficiency and the anti-tumor curative effect are improved, the liposome preparation has an inhibiting effect on human / mouse glioma cells, the wide clinical application potential is shown, and an efficient and low-toxicity novel treatment scheme is provided for glioma patients.
Owner:INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES

Preparation method of composition for relieving tinnitus symptom

The invention provides a preparation method of a composition for relieving tinnitus symptoms, which comprises the following steps: stirring and mixing a ginkgo leaf extract, an organic solvent and soya bean lecithin to obtain a component primary solution; adding gamma-aminobutyric acid and alpha-lipoic acid into the component primary liquid, uniformly mixing, and concentrating and purifying to obtain a phospholipidized complex; uniformly mixing soybean lecithin, sitosterol and an organic solvent, concentrating, adding a buffer solution to prepare a liposome mixed solution, carrying out ultrasonic dispersion, adding the phospholipid complex, stirring to obtain a core-shell structure mixed solution, filtering, and freeze-drying to obtain core-shell structure powder; the composition for relieving the tinnitus symptom is obtained by adding the active components and the auxiliaries into the core-shell structure powder, granulating and filling into capsules, a stable core-shell structure is formed by the prepared phosphatidylated complex and lipidosome, the fat solubility and stability of the composition are improved, and the blood-brain barrier transmittance is also improved.
Owner:FOSUN HAPPY GOU (SHENZHEN) TECH CO LTD